How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?

How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?

Bibliographic Details
Main Author:	Eric T Wong
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Glioma
Online Access:	http://www.jglioma.com/article.asp?issn=2589-6113;year=2023;volume=6;issue=3;spage=29;epage=30;aulast=Wong

Similar Items

Vorasidenib: A promising therapeutic breakthrough for diffuse isocitrate dehydrogenase mutant gliomas
by: Abdul Wahid, et al.
Published: (2023-08-01)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
by: Marco Gallus, et al.
Published: (2023-07-01)

Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
by: Ming-Yang Li, et al.
Published: (2015-01-01)

Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
by: Danielle Golub, et al.
Published: (2019-05-01)

Mutasi Isocitrate Dehydrogenase 1 dan 2 pada Glioma
by: Ni Putu Sriwidyani
Published: (2020-12-01)

Mutant Isocitrate Dehydrogenase 1 Expression Enhances Response of Gliomas to the Histone Deacetylase Inhibitor Belinostat
by: Chi-Ming Chang, et al.
Published: (2023-05-01)

Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
by: Yang Liu, et al.
Published: (2020-08-01)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
by: Dongming Yan, et al.
Published: (2022-06-01)

Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01)

The studies on the mechanism and inhibition of Isocitrate Dehydrogenases
by: Liu, X
Published: (2022)

The Association of Alpha-thalassemia X-Linked Intellectual Disability Mutation with Histopathological Grading in Isocitrate- Dehydrogenase-mutant Glioma
by: Alva Sinung Anindita, et al.
Published: (2023-12-01)

Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism
by: Li Su, et al.
Published: (2020-04-01)

Mechanistic and inhibition studies on isocitrate dehydrogenase 1
by: Liu, S
Published: (2019)

Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas
by: Lei-Ming Wang, et al.
Published: (2019-12-01)

Role of natural killer cells in isocitrate dehydrogenase 1/2 mutant glioma pathogenesis and emerging therapies
by: Xiaoran Zhang, et al.
Published: (2019-01-01)

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
by: Felix Neumaier, et al.
Published: (2023-03-01)

Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients
by: Auezova R, et al.
Published: (2019-04-01)

The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes
by: Tomoaki Ishida, et al.
Published: (2021-12-01)

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
by: Yang Liu, et al.
Published: (2023-04-01)

Histologic characterization of the immune infiltrate in isocitrate dehydrogenase wild-type and mutant World Health Organization Grade II and III gliomas
by: Josine A. E. M. Jansen, et al.
Published: (2018-01-01)

Diagnostic Accuracy of MRS in the Preoperative Identification of Isocitrate Dehydrogenase Mutation in Patients with Gliomas
by: Fahad Alkherayf, et al.
Published: (2023-01-01)

Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma
by: Yanfei Jia, et al.
Published: (2021-01-01)

The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells
by: Philip Dao Trong, et al.
Published: (2023-04-01)

Functional analysis of mutations in isocitrate dehydrogenase involved in gliomagenesis
by: Krell, D
Published: (2014)

Studies on human cancer variant and mycobacterial isocitrate dehydrogenases
by: Reinbold, R
Published: (2021)

Isocitrate dehydrogenase gene variants in cancer and their clinical significance
by: Cadoux-Hudson, T, et al.
Published: (2021)

Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
by: Hvinden, IC, et al.
Published: (2021)

Research Progress of Isocitrate Dehydrogenase Gene Mutation Therapy
by: LIN Meijia, et al.
Published: (2023-03-01)

Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight
by: Hamoud Al-Khallaf
Published: (2017-08-01)

Analysis of Isocitrate dehydrogenase (IDH) mutation in Gliomas---a call for neurosurgeons and pathologists in Pakistan
by: Muntaha Masood, et al.
Published: (2022-05-01)

Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
by: XiaoYong Pan, et al.
Published: (2019-11-01)

Influence of scalp block on oncological outcomes of high-grade glioma in adult patients with and without isocitrate dehydrogenase-1 mutation
by: Chao-Hsien Sung, et al.
Published: (2021-08-01)

Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
by: Liu, S, et al.
Published: (2020)

Research Progress and Prospects of Isocitrate Dehydrogenase Gene Mutation in Chondrosarcoma
by: ZHAO Jingjing, ZHANG Zhihong, ZHEN Junping
Published: (2024-04-01)

Identification of potential target genes for isocitrate dehydrogenase mutations in cholangiocarcinoma
by: WANG Di, LI Qing, TONG Wei-min, NIU Ya-mei
Published: (2020-04-01)

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
by: Ugo Testa, et al.
Published: (2020-08-01)

Cytosolic Isocitrate Dehydrogenase from Arabidopsis thaliana Is Regulated by Glutathionylation
by: Adnan Khan Niazi, et al.
Published: (2019-01-01)

Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase
by: Pengkai Sun, et al.
Published: (2020-12-01)

Correction: Gallus et al. Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. <i>Cancers</i> 2023, <i>15</i>, 3726
by: Marco Gallus, et al.
Published: (2023-12-01)

Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH).
by: Jinsung Yang, et al.
Published: (2017-08-01)